RECORDATI |
Market Closed -
Other stock markets
|
After market 15:59:30 | |||
| 50.5 EUR | -0.59% |
|
50.48 | -0.05% |
| 05-10 | Futures bullish; Mib restarts at 34,300 level | AN |
| 05-09 | Mib up, Nexi and Prysmian good after accounts | AN |
ETFs positioned on Recordati
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.52% | 5 M€ | +12.55% | ||
| 0.42% | 2 M€ | +11.01% | ||
| 0.32% | 242 M€ | +8.78% | ||
| 0.29% | 3 M€ | +9.95% | - | |
| 0.24% | 1,083 M€ | +3.56% | ||
| 0.20% | 17 M€ | +6.60% | - | |
| 0.06% | 6 M€ | -.--% | - | |
| 0.06% | 32 M€ | +7.48% | - | |
| 0.04% | 6 M€ | -.--% | ||
| 0.03% | 10 M€ | -3.35% | - | |
| 0.01% | 284 M€ | -.--% | ||
| 0.01% | 206 M€ | -.--% | ||
| 0.01% | 786 M€ | -.--% | ||
| 0.01% | 23 M€ | -.--% | - | |
| 0.01% | 283 M€ | +19.00% | ||
| 0.01% | 1,166 M€ | +0.26% | ||
| 0.01% | 607 M€ | +0.05% | ||
| 0.01% | 45 M€ | 0.00% | - | |
| 0.01% | 391 M€ | +8.67% | - | |
| 0.00% | 34 M€ | +8.24% | - | |
| 0.00% | 7 M€ | +0.11% | - |
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
Pharmaceuticals
Calendar
2024-05-19
- Final dividend
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
50.8
EUR
Average target price
52.24
EUR
Spread / Average Target
+2.83%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.42% | 11.29B | |
| +30.02% | 684B | |
| +30.34% | 568B | |
| -3.82% | 361B | |
| +18.11% | 329B | |
| +4.04% | 284B | |
| +16.21% | 240B | |
| +9.66% | 208B | |
| -6.83% | 200B | |
| +7.18% | 166B |
- Stock Market
- Equities
- REC Stock
- Funds and ETFs Recordati